Development of a prognostic nomogram and genetic insights for prostate cancer patients with secondary primary malignancies: A SEER retrospective cohort study and Mendelian randomization analysis

Documenti analoghi

• Sexual dysfunction after Rezum therapy for benign prostatic hyperplasia: A scoping review for the current insights and findings
  di: Ibrahim A. Khalil, et al.
  Pubblicazione: (2024)
• Technical development in high‐intensity focused ultrasound for localized prostate cancer: Intraoperative compression of the prostate
  di: Sunao Shoji, et al.
  Pubblicazione: (2026)
• Novel reference gene microseminoprotein‐beta based prostate cancer antigen 3 urine test: Enhanced diagnostic performance for prostate cancer and feasibility of non‐digital rectal examination urine sampling
  di: Jianglei Xu, et al.
  Pubblicazione: (2026)
• Epidemiology and organized testing for the diagnosis of prostate cancer in Sweden
  di: Eugen Y. H. Wang
  Pubblicazione: (2025)
• The impact of UroLift implants on prostate MRI imaging
  di: Jesse Persily, et al.
  Pubblicazione: (2025)